# Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae

> **NCT00176995** · PHASE2 · COMPLETED · sponsor: **Hordinsky, Maria K., MD** · enrollment: 15 (—)

## Conditions studied

- Pseudofolliculitis Barbae

## Interventions

- **DRUG:** 15% Eflornithine Hdyrochloride

## Key facts

- **NCT ID:** NCT00176995
- **Lead sponsor:** Hordinsky, Maria K., MD
- **Sponsor class:** INDIV
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1999-03
- **Primary completion:** —
- **Final completion:** 2000-10
- **Target enrollment:** 15 (—)
- **Last updated:** 2006-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00176995

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00176995, "Effect of 15% Eflornithine Hydrochloride Cream on African-American Males With Pseudofolliculitis Barbae". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00176995. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*